LOH-proficient embryonic stem cells: a model of cancer progenitor cells?

Trends in Genetics

Volumn 23, Issue 4, 2007, Pages 154-157

  Bielas, Jason H ^a   Venkatesan, Ranga N ^a   Loeb, Lawrence A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER STEM CELL; CARCINOGENESIS; EMBRYONIC STEM CELL; GENE FREQUENCY; HETEROZYGOSITY LOSS; HUMAN; INDUCED MUTATION; MOLECULAR MIMICRY; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; EMBRYONIC STEM CELLS; HUMANS; LOSS OF HETEROZYGOSITY; MODELS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 33947625609     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2007.02.009     Document Type: Short Survey

References (24)

1. Lengauer C., et al. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
2. Feinberg A.P., et al. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7 (2006) 21-33
3. Stoler D.L., et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 15121-15126
4. Nowell P.C. Chromosomes and cancer: the evolution of an idea. Adv. Cancer Res. 62 (1993) 1-17
5. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
6. Weinberg R.A. The Biology of Cancer (2006), Garland Science
7. Bielas J.H., et al. Human cancers express a mutator phenotype. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 18238-18242
8. Bielas J.H., and Loeb L.A. Quantification of random genomic mutations. Nat. Methods 2 (2005) 285-290
9. Bielas J.H., and Loeb L.A. Mutator phenotype in cancer: timing and perspectives. Environ. Mol. Mutagen. 45 (2005) 206-213
10. Cervantes R.B., et al. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3586-3590
11. Loeb L.A., et al. Multiple mutations and cancer. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 776-781
12. Wang T.L., et al. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 3076-3080
13. Tomlinson I.P.M., et al. The mutation rate and cancer. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 14800-14803
14. Donahue S.L., et al. Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 11642-11646
15. Hendricks C.A., and Engelward B.P. Recombomice: the past, present, and future of recombination-detection in mice. DNA Repair (Amst.) 3 (2004) 1255-1261
16. Kops G.J., et al. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer 5 (2005) 773-785
17. Mortensen R.M., et al. Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12 (1992) 2391-2395
18. Wyborski D.L., et al. Development of a rat cell line containing stably integrated copies of a lambda/lacI shuttle vector. Mutat. Res. 334 (1995) 161-165
19. Monroe J.J., et al. A comparative study of in vivo mutation assays: analysis of hprt, lacl, cll/cl and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice. Mutat. Res. 421 (1998) 121-136
20. Shima N., et al. Dietary restriction during murine development provides protection against MNU-induced mutations. Mutat. Res. 470 (2000) 189-200
21. Wijnhoven S.W., et al. Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes. Carcinogenesis 24 (2003) 139-144
22. 6-methylguanine DNA methyltransferase substrate specificity and temperature sensitivity. J. Biol. Chem. 268 (1993) 19802-19809
23. Lefebvre L., et al. Selection for transgene homozygosity in embryonic stem cells results in extensive loss of heterozygosity. Nat. Genet. 27 (2001) 257-258
24. Singer B., and Grunberger D. The Molecular Biology of Mutagens and Carcinogens (1983), Plenum Press